Cargando…

Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data

BACKGROUND: Diabetic nephropathy (DN) is a prevalent and debilitating disease that represents the leading cause of chronic kidney disease which imposes public health challenges Tongmai Jiangtang capsule (TMJT) is commonly used for the treatment of DN, albeit its underlying mechanisms of action are s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Cui, Xin, Zhang, Xuming, Xie, Zhuoting, Wang, Weili, Xi, Junyu, Xie, Yanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654657/
https://www.ncbi.nlm.nih.gov/pubmed/38027201
http://dx.doi.org/10.3389/fendo.2023.1172226
_version_ 1785136672389726208
author Liu, Yi
Cui, Xin
Zhang, Xuming
Xie, Zhuoting
Wang, Weili
Xi, Junyu
Xie, Yanming
author_facet Liu, Yi
Cui, Xin
Zhang, Xuming
Xie, Zhuoting
Wang, Weili
Xi, Junyu
Xie, Yanming
author_sort Liu, Yi
collection PubMed
description BACKGROUND: Diabetic nephropathy (DN) is a prevalent and debilitating disease that represents the leading cause of chronic kidney disease which imposes public health challenges Tongmai Jiangtang capsule (TMJT) is commonly used for the treatment of DN, albeit its underlying mechanisms of action are still elusive. METHODS: This study retrieved databases to identify the components and collect the targets of TMJT and DN. Target networks were constructed to screen the core components and targets. Samples from the GEO database were utilized to perform analyses of targets and immune cells and obtain significantly differentially expressed core genes (SDECGs). We also selected a machine learning model to screen the feature genes and construct a nomogram. Furthermore, molecular docking, another GEO dataset, and Mendelian randomization (MR) were utilized for preliminary validation. We subsequently clustered the samples based on SDECG expression and consensus clustering and performed analyses between the clusters. Finally, we scored the SDECG score and analyzed the differences between clusters. RESULTS: This study identified 13 SDECGs between DN and normal groups which positively regulated immune cells. We also identified five feature genes (CD40LG, EP300, IL1B, GAPDH, and EGF) which were used to construct a nomogram. MR analysis indicated a causal link between elevated IL1B levels and an increased risk of DN. Clustering analysis divided DN samples into four groups, among which, C1 and CI were mainly highly expressed and most immune cells were up-regulated. C2 and CII were the opposite. Finally, we found significant differences in SDECG scores between C1 and C2, CI and CII, respectively. CONCLUSION: TMJT may alleviate DN via core components (e.g. Denudatin B, hancinol, hirudinoidine A) targeting SDECGs (e.g. SRC, EGF, GAPDH), with the involvement of feature genes and modulation of immune and inflammation-related pathways. These findings have potential implications for clinical practice and future investigations.
format Online
Article
Text
id pubmed-10654657
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106546572023-01-01 Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data Liu, Yi Cui, Xin Zhang, Xuming Xie, Zhuoting Wang, Weili Xi, Junyu Xie, Yanming Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Diabetic nephropathy (DN) is a prevalent and debilitating disease that represents the leading cause of chronic kidney disease which imposes public health challenges Tongmai Jiangtang capsule (TMJT) is commonly used for the treatment of DN, albeit its underlying mechanisms of action are still elusive. METHODS: This study retrieved databases to identify the components and collect the targets of TMJT and DN. Target networks were constructed to screen the core components and targets. Samples from the GEO database were utilized to perform analyses of targets and immune cells and obtain significantly differentially expressed core genes (SDECGs). We also selected a machine learning model to screen the feature genes and construct a nomogram. Furthermore, molecular docking, another GEO dataset, and Mendelian randomization (MR) were utilized for preliminary validation. We subsequently clustered the samples based on SDECG expression and consensus clustering and performed analyses between the clusters. Finally, we scored the SDECG score and analyzed the differences between clusters. RESULTS: This study identified 13 SDECGs between DN and normal groups which positively regulated immune cells. We also identified five feature genes (CD40LG, EP300, IL1B, GAPDH, and EGF) which were used to construct a nomogram. MR analysis indicated a causal link between elevated IL1B levels and an increased risk of DN. Clustering analysis divided DN samples into four groups, among which, C1 and CI were mainly highly expressed and most immune cells were up-regulated. C2 and CII were the opposite. Finally, we found significant differences in SDECG scores between C1 and C2, CI and CII, respectively. CONCLUSION: TMJT may alleviate DN via core components (e.g. Denudatin B, hancinol, hirudinoidine A) targeting SDECGs (e.g. SRC, EGF, GAPDH), with the involvement of feature genes and modulation of immune and inflammation-related pathways. These findings have potential implications for clinical practice and future investigations. Frontiers Media S.A. 2023-11-01 /pmc/articles/PMC10654657/ /pubmed/38027201 http://dx.doi.org/10.3389/fendo.2023.1172226 Text en Copyright © 2023 Liu, Cui, Zhang, Xie, Wang, Xi and Xie https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liu, Yi
Cui, Xin
Zhang, Xuming
Xie, Zhuoting
Wang, Weili
Xi, Junyu
Xie, Yanming
Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title_full Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title_fullStr Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title_full_unstemmed Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title_short Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
title_sort exploring the potential mechanisms of tongmai jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654657/
https://www.ncbi.nlm.nih.gov/pubmed/38027201
http://dx.doi.org/10.3389/fendo.2023.1172226
work_keys_str_mv AT liuyi exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT cuixin exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT zhangxuming exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT xiezhuoting exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT wangweili exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT xijunyu exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata
AT xieyanming exploringthepotentialmechanismsoftongmaijiangtangcapsulesintreatingdiabeticnephropathythroughmultidimensionaldata